| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.85B | -5.3% |
| Cost of Revenue | $1.30B | -4.1% |
| Gross Profit | $542.9M | -8.2% |
| R&D Expense | $47.8M | +14.6% |
| SG&A Expense | $314.0M | -19.0% |
| Operating Income | $177.9M | +10.1% |
| Interest Expense | $0 | — |
| Pre-tax Income | $41.2M | -76.4% |
| Income Tax | $5.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $289.2M | +42.0% |
| Accounts Receivable | $341.7M | -5.0% |
| Inventory | $301.0M | +0.3% |
| Current Assets | $956.6M | +8.0% |
| Total Assets | $1.73B | +1.6% |
| Current Liabilities | $371.4M | -0.0% |
| Total Liabilities | $518.6M | -7.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $184.5M | -11.0% |
| Capital Expenditures | $41.4M | -33.3% |
| Investing Cash Flow | -$62.0M | +44.5% |
| Financing Cash Flow | -$35.3M | +9.5% |
| Free Cash Flow | $143.1M | -1.4% |
| -84.1% |
| Net Income | $35.6M | -74.4% |
| EPS (Basic) | $1.43 | -74.5% |
| EPS (Diluted) | $1.42 | -74.5% |
| Stockholders' Equity |
| $1.21B |
| +5.6% |